These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9626586

  • 1. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
    Schnitzer E, Pinchuk I, Fainaru M, Lichtenberg D, Yedgar S.
    Free Radic Biol Med; 1998 May; 24(7-8):1294-303. PubMed ID: 9626586
    [Abstract] [Full Text] [Related]

  • 2. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
    Steinbrecher UP, Pritchard PH.
    J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
    [Abstract] [Full Text] [Related]

  • 3. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
    Liapikos TA, Antonopoulou S, Karabina SP, Tsoukatos DC, Demopoulos CA, Tselepis AD.
    Biochim Biophys Acta; 1994 Jun 02; 1212(3):353-60. PubMed ID: 8199206
    [Abstract] [Full Text] [Related]

  • 4. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
    Subramanian VS, Goyal J, Miwa M, Sugatami J, Akiyama M, Liu M, Subbaiah PV.
    Biochim Biophys Acta; 1999 Jul 09; 1439(1):95-109. PubMed ID: 10395969
    [Abstract] [Full Text] [Related]

  • 5. Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation.
    Goyal J, Wang K, Liu M, Subbaiah PV.
    J Biol Chem; 1997 Jun 27; 272(26):16231-9. PubMed ID: 9195924
    [Abstract] [Full Text] [Related]

  • 6. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC, Arborati M, Liapikos T, Clay KL, Murphy RC, Chapman MJ, Ninio E.
    Arterioscler Thromb Vasc Biol; 1997 Dec 27; 17(12):3505-12. PubMed ID: 9437199
    [Abstract] [Full Text] [Related]

  • 7. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase.
    Dentan C, Tselepis AD, Chapman MJ, Ninio E.
    Biochim Biophys Acta; 1996 Feb 16; 1299(3):353-7. PubMed ID: 8597590
    [Abstract] [Full Text] [Related]

  • 8. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA.
    J Clin Invest; 1995 Feb 16; 95(2):774-82. PubMed ID: 7860760
    [Abstract] [Full Text] [Related]

  • 9. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.
    Sasabe N, Keyamura Y, Obama T, Inoue N, Masuko Y, Igarashi Y, Aiuchi T, Kato R, Yamaguchi T, Kuwata H, Iwamoto S, Miyazaki A, Hara S, Yoshikawa T, Itabe H.
    Lipids Health Dis; 2014 Mar 14; 13():48. PubMed ID: 24625108
    [Abstract] [Full Text] [Related]

  • 10. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA, Elisaf MC, Goudevenos J, Siamopoulos KC, Sideris D, Tselepis AD.
    Atherosclerosis; 1996 Aug 23; 125(1):121-34. PubMed ID: 8831934
    [Abstract] [Full Text] [Related]

  • 11. The use of C6-NBD-PC for assaying phospholipase A2-activity: scope and limitations.
    Meyuhas D, Yedgar S, Rotenberg M, Reisfeld N, Lichtenberg D.
    Biochim Biophys Acta; 1992 Mar 25; 1124(3):223-32. PubMed ID: 1576162
    [Abstract] [Full Text] [Related]

  • 12. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD.
    Eur J Clin Invest; 1997 Jul 25; 27(7):595-602. PubMed ID: 9263748
    [Abstract] [Full Text] [Related]

  • 13. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
    Tselepis AD, John Chapman M.
    Atheroscler Suppl; 2002 Dec 25; 3(4):57-68. PubMed ID: 12573364
    [Abstract] [Full Text] [Related]

  • 14. Phospholipase A(2) activity in non-glycated and glycated low density lipoproteins.
    Sakurai T, Yamamoto Y, Baba N, Nakano M.
    Biochim Biophys Acta; 1996 May 31; 1301(1-2):85-9. PubMed ID: 8652655
    [Abstract] [Full Text] [Related]

  • 15. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
    Min JH, Wilder C, Aoki J, Arai H, Inoue K, Paul L, Gelb MH.
    Biochemistry; 2001 Apr 17; 40(15):4539-49. PubMed ID: 11294621
    [Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E.
    Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
    Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM.
    J Biol Chem; 1989 Apr 05; 264(10):5331-4. PubMed ID: 2494162
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.